Compare Mounjaro and Wegovy: Private vs NHS Route
The NHS route for accessing weight management treatments typically requires GP referral to specialist services, followed by extensive waiting periods often exceeding six months. Private prescription services eliminate these barriers, allowing you to compare Mounjaro and Wegovy options directly with qualified prescribers. EverydayMeds provides immediate access to both treatments through our GPhC-registered pharmacy (#9012878), ensuring you receive the same genuine medications available through NHS pathways. Our clinical team can assess your suitability for either treatment based on your individual health profile and preferences.
When you compare Mounjaro and Wegovy through private channels, you gain control over timing and treatment choice. NHS weight management services often have limited medication options due to commissioning decisions, whereas private prescribers can recommend the most suitable treatment based purely on clinical factors. This personalised approach ensures you start with the medication that best matches your lifestyle, storage requirements, and dosing preferences without external constraints affecting your care pathway.
Wegovy vs Mounjaro: Pricing and Value Comparison
Wegovy pricing through EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle provides both 0.25mg and 0.5mg pens for £169.99, while the Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99. New customers can apply discount code FIRST40 at checkout, with returning customers using DOSE25 for additional savings.
When you compare Mounjaro and Wegovy costs, consider the complete treatment journey including dose escalation phases and long-term maintenance requirements. Both treatments require gradual dose increases over 16-20 weeks before reaching maintenance levels, making bundle options particularly valuable for treatment continuity. Our Getting Started bundles ensure seamless progression through initial doses, whilst Stay Steady bundles provide consistent supply at your optimal maintenance dose without interruption.
Clinical Evidence: How Mounjaro and Wegovy Compare
Wegovy demonstrated significant efficacy in the landmark STEP trials, with patients achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The STEP 2 trial showed 9.6% weight reduction in patients with type 2 diabetes, whilst STEP 3 achieved 16% with intensive behavioural support. STEP 5 confirmed sustainability with clinically studied weight loss maintained at two years.
Mounjaro's clinical programme showed robust results in the SURMOUNT trials, though direct head-to-head comparisons aren't available due to different trial designs and patient populations. When prescribers compare Mounjaro and Wegovy, they consider individual patient factors rather than trial percentages alone. Both medications require clinical assessment to determine suitability, with treatment success depending on adherence to prescribed dosing schedules and lifestyle modifications.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones produced in your intestines after eating. This mechanism reduces appetite by acting on brain centres controlling hunger and satiety, helping you feel fuller after smaller meals. GLP-1 receptors also slow gastric emptying, prolonging the feeling of fullness and reducing food cravings throughout the day. The once-weekly injection maintains steady medication levels, providing consistent appetite control without daily dosing requirements. When you compare Mounjaro and Wegovy mechanisms, Wegovy's singular GLP-1 focus offers proven, targeted appetite regulation that has been extensively studied across diverse patient populations.
Private Prescription Process: From Assessment to Delivery
EverydayMeds streamlines access to both treatments through our three-minute online clinical assessment, eliminating lengthy GP appointments and specialist referrals. Our qualified prescribers review your submission within three working days (24 hours with express service), determining suitability for either Wegovy or Mounjaro based on your medical history and weight management goals. Once approved, your prescription-only medicine ships via temperature-controlled, cold-chain delivery ensuring medication integrity from our GPhC-registered pharmacy directly to your door. This efficient process means you can compare Mounjaro and Wegovy options with expert guidance, then begin treatment within 72 hours of your initial enquiry. No waiting rooms, no repeated appointments, just professional clinical care designed around your schedule and privacy requirements.
Storage and Practical Considerations
Wegovy requires refrigeration at 2-8°C before first use but offers superior travel flexibility, remaining stable at room temperature below 30°C for up to six weeks once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules. The FlexTouch pen design provides intuitive injection experience with clear dose indicators and safety features preventing accidental overdosing. Dose escalation follows a fixed 16-week schedule starting at 0.25mg, doubling every four weeks until reaching 2.4mg maintenance dose. When you compare Mounjaro and Wegovy practically, consider your lifestyle patterns, travel frequency, and comfort with injection routines to determine which treatment integrates most seamlessly with your daily life.
Dual Mechanism vs Single Target: Understanding Your Options
The fundamental difference when you compare Mounjaro and Wegovy lies in their receptor targeting approaches. Wegovy's selective GLP-1 agonism provides focused appetite control through well-established pathways, whilst Mounjaro's dual GIP/GLP-1 mechanism offers broader metabolic effects. This distinction influences prescriber recommendations based on individual patient profiles, including diabetes status, cardiovascular risk factors, and previous treatment responses.
Private prescription access allows thorough discussion of these mechanistic differences without time constraints typical in NHS consultations. Your EverydayMeds prescriber can explore which approach suits your physiology and treatment goals, considering factors like injection frequency tolerance, storage requirements, and long-term maintenance preferences. This personalised consultation ensures your treatment choice aligns with both clinical evidence and practical lifestyle considerations that determine long-term adherence success.
Start Your Weight Management Journey Today
EverydayMeds eliminates barriers between you and effective weight management treatment through our streamlined private prescription service. New customers receive additional value with discount code FIRST40 applied at checkout, whilst our comprehensive bundle options ensure treatment continuity throughout dose escalation phases. Our GPhC-registered pharmacy (#9012878) ensures genuine Novo Nordisk Wegovy with full cold-chain integrity from manufacture to your door. Whether you choose Wegovy or decide to compare Mounjaro and Wegovy options with our clinical team, professional support guides your decision-making process. Begin your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy and take control of your weight management journey without delay or bureaucratic obstacles.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026